anmelden
SPI
18.684,24
PKT
+101,75
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.10.17 | Roche Hold | Kepler Cheuvreux | |
| 20.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.10.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 20.10.17 | Nestlé buy | Baader Bank | |
| 20.10.17 | Roche Reduce | HSBC | |
| 19.10.17 | Roche Neutral | UBS AG | |
| 19.10.17 | Roche Hold | Baader Bank | |
| 19.10.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 19.10.17 | Nestlé buy | Baader Bank | |
| 19.10.17 | Nestlé buy | UBS AG | |
| 19.10.17 | Roche overweight | JP Morgan Chase & Co. | |
| 19.10.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 18.10.17 | Roche Neutral | Citigroup Corp. | |
| 18.10.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 17.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 16.10.17 | Holcim Neutral | UBS AG | |
| 16.10.17 | Roche overweight | JP Morgan Chase & Co. | |
| 16.10.17 | Roche buy | Jefferies & Company Inc. | |
| 16.10.17 | Novartis buy | Jefferies & Company Inc. | |
| 16.10.17 | Roche Neutral | Credit Suisse Group | |
| 13.10.17 | Givaudan Neutral | BNP PARIBAS | |
| 12.10.17 | Holcim Neutral | BNP PARIBAS | |
| 12.10.17 | Novartis buy | HSBC | |
| 12.10.17 | UBS buy | HSBC | |
| 12.10.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 11.10.17 | Nestlé overweight | Morgan Stanley | |
| 11.10.17 | ObsEva Buy | H.C. Wainwright & Co. | |
| 11.10.17 | Swiss Re Neutral | BNP PARIBAS | |
| 11.10.17 | Swiss Re Neutral | BNP PARIBAS | |
| 11.10.17 | ABB (Asea Brown Boveri) Hold | HSBC | |
| 11.10.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 11.10.17 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 10.10.17 | Swiss Re Sell | UBS AG | |
| 10.10.17 | Givaudan Neutral | UBS AG | |
| 10.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 10.10.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG |